Turning germ cells into stem cells

Current Opinion in Genetics and Development

Volumn 13, Issue 5, 2003, Pages 463-471

  Donovan, Peter J ^a   De Miguel, Maria P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; STEM CELL FACTOR;

CANCER SUSCEPTIBILITY; CARCINOMA CELL; CELL LINEAGE; CELL TRANSFORMATION; CHIMERA; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL; SOMATIC CELL GENETICS; STEM CELL; TESTIS CARCINOMA;

ANIMALIA; MAMMALIA;

EID: 0141450321     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2003.08.010     Document Type: Review

References (104)

1. Donovan P.J., Gearhart J. The end of the beginning for pluripotent stem cells. Nature. 414:2001;92-97.
2. Campbell K.H., McWhir J., Ritchie W.A., Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature. 380:1996;64-66.
3. Wakayama T., Perry A.C., Zuccotti M., Johnson K.R., Yanagimachi R. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature. 394:1998;369-374.
4. Lawson K.A., Hage W.J. Clonal analysis of the origin of primordial germ cells in the mouse. Ciba Foundation Symposium. 182:1994;68-84. discussion 84-91.
5. Lawson K.A., Dunn N.R., Roelen B.A., Zeinstra L.M., Davis A.M., Wright C.V., Korving J.P., Hogan B.L. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev. 13:1999;424-436.
6. Pera M.F., Reubinoff B., Trounson A. Human embryonic stem cells. J. Cell. Sci. 113:2000;5-10.
7. Saitou M., Barton S.C., Surani M.A. A molecular programme for the specification of germ cell fate in mice. Nature. 418:2002;293-300 The authors describe a technically very challenging but ultimately successful approach to identifying genes involved in early germline development. The identified genes provide important new clues as to the molecular mechanisms regulating early germline segregation and which may distinguish PGCs from other cells of the epiblast.
8. Tanaka S.S., Matsui Y. Developmentally regulated expression of mil-1 and mil-2, mouse interferon-induced transmembrane protein like genes, during formation and differentiation of primordial germ cells. Gene Expr. Patterns. 2:2002;297-303 In this paper, the authors successfully searched for genes that might be differentially expressed between PGCs and ES cells. The identification of these genes provides new insight into the mechanisms responsible for segregation of germ cells from somatic cells.
9. Wylie C. Germ cells. Cell. 96:1999;165-174.
10. Donovan PJ, De Miguel MP: The role of C-Kit/Kit ligand axis in mammalian gametogeneis. In Transgenics in Endocrinology. Edited by Matzuk M, Brown CW, Kumar TR: Humana Press; 2001:147-163.
11. Toyooka Y., Tsunekawa N., Takahashi Y., Matsui Y., Satoh M., Noce T. Expression and intracellular localization of mouse Vasa-homologue protein during germ cell development. Mech. Dev. 93:2000;139-149.
12. Donovan P.J., Stott D., Cairns L.A., Heasman J., Wylie C.C. Migratory and postmigratory mouse primordial germ cells behave differently in culture. Cell. 44:1986;831-838.
13. Chuma S., Nakatsuji N. Autonomous transition into meiosis of mouse fetal germ cells in vitro and its inhibition by gp130-mediated signaling. Dev. Biol. 229:2001;468-479.
14. Nakatsuji N., Chuma S. Differentiation of mouse primordial germ cells into female or male germ cells. Int. J. Dev. Biol. 45:2001;541-548.
15. Stevens L.C. The biology of teratomas. Adv. Morphog. 6:1967;1-31.
16. Matin A, Collin GB, Varnum DS, Nadeau JH: Testicular teratocarcinogenesis in mice - a review. In Neoplastic Transformation of Testicular Germ Cells, vol 106. Edited by Meyts ER, Grigor KM, Skakkebaek NE. AMPIS; 1998:174-182.
17. Stevens L.C. Origin of testicular teratomas from primordial germ cells in mice. J. Natl. Cancer Inst. 38:1967;549-552.
18. Stevens L.C. Genetic influences on teratocarcinogenesis and parthenogenesis. Prog. Clin. Biol. Res. 45:1981;93-104.
19. Youngren K.K., Nadeau J.H., Matin A. Testicular cancer susceptibility in the 129.MOLF-Chr19 mouse strain: additive effects, gene interactions and epigenetic modifications. Hum. Mol. Genet. 12:2003;389-398 This paper describes a continuation of a powerful genetic approach to identifying testicular cancer susceptibility genes using chromosome substitution strains of mice. Here the authors identify several genes on mouse chromosome 19 that are testicular cancer susceptibility genes. In addition, they propose a novel epigenetic model to explain their data.
20. Muller A.J., Teresky A.K., Levine A.J. A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13. Proc. Natl. Acad. Sci. USA. 97:2000;8421-8426.
21. Takabayashi S., Sasaoka Y., Yamashita M., Tokumoto T., Ishikawa K., Noguchi M. Novel growth factor supporting survival of murine primordial germ cells: evidence from conditioned medium of ter fetal gonadal somatic cells. Mol. Reprod. Dev. 60:2001;384-396.
22. Matin A., Collin G.B., Asada Y., Varnum D., Nadeau J.H. Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain. Nat. Genet. 23:1999;237-240.
23. Skakkebaek N.E. Trends in male reproductive health. Environmental aspects. Adv. Exp. Med. Biol. 444:1998;1-2. discussion 3-4.
24. Moller H., Prener A., Skakkebaek N.E. Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control. 7:1996;264-274.
25. Collins G.M., Kim D.U., Logrono R., Rickert R.R., Zablow A., Breen J.L. Pure seminoma arising in androgen insensitivity syndrome (testicular feminization syndrome): a case report and review of the literature. Mod. Pathol. 6:1993;89-93.
26. Giwercman A., Lenz S., Skakkebaek N.E. Carcinoma in situ in atrophic testis: biopsy based on abnormal ultrasound pattern. Br. J. Urol. 72:1993;118-120.
27. Petersen P.M., Skakkebaek N.E., Giwercman A. Gonadal function in men with testicular cancer: biological and clinical aspects. APMIS. 106:1998;24-34.
28. Muller J., Skakkebaek N.E. Gonadal malignancy in individuals with sex chromosome anomalies. Birth Defects Orig. Artic. Ser. 26:1990;247-255.
29. Skakkebaek N.E., Rajpert-De Meyts E., Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16:2001;972-978.
30. Moller H., Skakkebaek N.E. Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control. 8:1997;904-912.
31. Auger J., Kunstmann J.M., Czyglik F., Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N. Engl. J. Med. 332:1995;281-285.
32. Norgil Damgaard I., Main K.M., Toppari J., Skakkebaek N.E. Impact of exposure to endocrine disrupters in utero and in childhood on adult reproduction. Best Pract. Res. Clin. Endocrinol. Metab. 16:2002;289-309.
33. Gibas Z., Prout G.R., Pontes J.E., Sandberg A.A. Chromosome changes in germ cell tumors of the testis. Cancer Genet. Cytogenet. 19:1986;245-252.
34. Looijenga L.H., Zafarana G., Grygalewicz B., Summersgill B., Debiec-Rychter M., Veltman J., Schoenmakers E.F., Rodriguez S., Jafer O., Clark J.et al. Role of gain of 12p in germ cell tumour development. APMIS. 111:2003;161-171. discussion 172-173.
35. Delozier-Blanchet C.D., Engel E., Walt H. Isochromosome 12p in malignant testicular tumors. Cancer Genet. Cytogenet. 15:1985;375-376.
36. Schmidt B.A., Rose A., Steinhoff C., Strohmeyer T., Hartmann M., Ackermann R. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Cancer Res. 61:2001;4214-4221.
37. Sicinski P., Donaher J.L., Geng Y., Parker S.B., Gardner H., Park M.Y., Robker R.L., Richards J.S., McGinnis L.K., Biggers J.D.et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 384:1996;470-474.
38. Olie R.A., Looijenga L.H., Boerrigter L., Top B., Rodenhuis S., Langeveld A., Mulder M.P., Oosterhuis J.W. N- and KRAS mutations in primary testicular germ cell tumors: incidence and possible biological implications. Genes Chromosomes Cancer. 12:1995;110-116.
39. Roelofs H., Mostert M.C., Pompe K., Zafarana G., Oorschot M., van Gurp R.J.H.L.M., Gillis A.J.M., Stoop H., Beverloo B., Oosterhuis J.W.et al. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am. J. Pathol. 157:2000;1155-1166.
40. Eid H., Institoris E., Geczi L., Bodrogi I., Bak M. mdm-2 expression in human testicular germ-cell tumors and its clinical value. Anticancer Res. 19:1999;3485-3490.
41. Riou G., Barrois M., Prost S., Terrier M.J., Theodore C., Levine A.J. The p53 and mdm-2 genes in human testicular germ-cell tumors. Mol. Carcinog. 12:1995;124-131.
42. Harvey M., McArthur M.J., Montgomery C.A. Jr., Bradley A., Donehower L.A. Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 7:1993;938-943.
43. Rodriguez S., Jafer O., Goker H., Summersgill B.M., Zafarana G., Gillis A.J., van Gurp R.J., Oosterhuis J.W., Lu Y.J., Huddart R.et al. Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene. 22:2003;1880-1891.
44. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 113:2003;631-642 The authors identify a new player, Nanog, in the regulatory pathways that control developmental potency in mammals. Nanog-deficient ICM fails to form epiblast and differentiates into parietal endoderm-like cells.
45. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 113:2003;643-655 The authors describe an ingenious scheme to identify new regulators of ES cell growth. They also go further to show that Nanog is expressed in PGCs in the E11.5 gonad.
46. Wang S.H., Tsai M.S., Chiang M.F., Li H. A novel NK-type homeobox gene, ENK (early embryo specific NK), preferentially expressed in embryonic stem cells. Gene Expr. Patterns. 3:2003;99-103.
47. Rajpert-De Meyts E., Jorgensen N., Brondum-Nielsen K., Muller J., Skakkebaek N.E. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS. 106:1998;198-204.
48. Tian Q., Frierson H.F. Jr., Krystal G.W., Moskaluk C.A. Activating c-Kit gene mutations in human germ cell tumors. Am. J. Pathol. 154:1999;1643-1647.
49. Shuin T., Misaki H., Kubota Y., Yao M., Hosaka M. Differential expression of protooncogenes in human germ cell tumors of the testis. Cancer. 73:1994;1721-1727.
50. Strohmeyer T., Reissmann P., Cordon-Cardo C., Hartmann M., Ackermann R., Slamon D.J. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc. Natl. Acad. Sci. USA. 88:1991;6662-6666.
51. Dolci S., Williams D.E., Ernst M.K., Resnick J.L., Brannan C.I., Lock L.F., Lyman S.D., Boswell H.S., Donovan P.J. Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature. 352:1991;809-811.
52. Godin I., Deed R., Cooke J., Zsebo K., Dexter M., Wylie C.C. Effects of the steel gene product on mouse primordial germ cells in culture. Nature. 352:1991;807-809.
53. Matsui Y., Toksoz D., Nishikawa S., Williams D., Zsebo K., Hogan B.L. Effect of steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture. Nature. 353:1991;750-752.
54. Matsui Y., Zsebo K., Hogan B.L. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell. 70:1992;841-847.
55. Resnick J.L., Bixler L.S., Cheng L., Donovan P.J. Long-term proliferation of mouse primordial germ cells in culture. Nature. 359:1992;550-551.
56. Shamblott M.J., Axelman J., Wang S., Bugg E.M., Littlefield J.W., Donovan P.J., Blumenthal P.D., Huggins G.R., Gearhart J.D. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA. 95:1998;13726-13731.
57. Thomson J.A., Odorico J.S. Human embryonic stem cell and embryonic germ cell lines. Trends Biotechnol. 18:2000;53-57.
58. Dolci S., Pesce M., De Felici M. Combined action of stem cell factor, leukemia inhibitory factor, and cAMP on in vitro proliferation of mouse primordial germ cells. Mol. Reprod. Dev. 35:1993;134-139.
59. Akira S., Yoshida K., Tanaka T., Taga T., Kishimoto T. Targeted disruption of the IL-6 related genes: gp130 and NF-IL-6. Immunol. Rev. 148:1995;221-253.
60. Koshimizu U., Taga T., Watanabe M., Saito M., Shirayoshi Y., Kishimoto T., Nakatsuji N. Functional requirement of gp130-mediated signaling for growth and survival of mouse primordial germ cells in vitro and derivation of embryonic germ (EG) cells. Development. 122:1996;1235-1242.
61. Donovan P.J. Growth factor regulation of mouse primordial germ cell development. Curr. Top. Dev. Biol. 29:1994;189-225.
62. Boilly B., Vercoutter-Edouart A.S., Hondermarck H., Nurcombe V., Le Bourhis X., Fernig D.G. FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Fact. Rev. 11:2000;295-302.
63. Goldfarb M. Signaling by fibroblast growth factors: the inside story. Science STKE. 2001:2001;PE37.
64. Resnick J.L., Ortiz M., Keller J.R., Donovan P.J. Role of fibroblast growth factors and their receptors in mouse primordial germ cell growth. Biol. Reprod. 59:1998;1224-1229.
65. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature. 411:2001;355-365.
66. Thomas G., Hall M.N. TOR signalling and control of cell growth. Curr. Opin. Cell. Biol. 9:1997;782-787.
67. Penuel E., Martin G.S. Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol. Biol. Cell. 10:1999;1693-1703.
68. Parganas E., Wang D., Stravopodis D., Topham D.J., Marine J.C., Teglund S., Vanin E.F., Bodner S., Colamonici O.R., van Deursen J.M.et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 93:1998;385-395.
69. Pawson T., Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science. 278:1997;2075-2080.
70. Pawson T. Regulation and targets of receptor tyrosine kinases. Eur. J. Cancer. 38:2002;S3-10.
71. Ekholm S.V., Reed S.I. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell. Biol. 12:2000;676-684.
72. De Miguel M.P., Cheng L., Holland E.C., Federspiel M.J., Donovan P.J. Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer. Proc. Natl. Acad. Sci. USA. 99:2002;10458-10463 The authors demonstrate the use of retroviral vectors to manipulate gene expression in PGCs and employ this technology to dissect the c-Kit signaling pathway. Furthermore, they demonstrate that the AKT kinase plays a critical role in mediating PGC growth.
73. Blume-Jensen P., Jiang G., Hyman R., Lee K.F., O'Gorman S., Hunter T. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3′-kinase is essential for male fertility. Nat. Genet. 24:2000;157-162.
74. Timokhina I., Kissel H., Stella G., Besmer P. Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation. EMBO J. 17:1998;6250-6262.
75. Kimura T., Suzuki A., Fujita Y., Yomogida K., Lomeli H., Asada N., Ikeuchi M., Nagy A., Mak T.W., Nakano T. Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development. 130:2003;1691-1700 The authors provide one of the first descriptions of PGC-specific gene targetting using the Cre-lox system, making use of mice expressing Cre recombinase from the TNAP promoter. Critically, this work demonstrates the important role that the PTEN molecule plays in regulating PGC growth, EG cell formation and the development of testicular cancer.
76. Stewart C.L., Gadi I., Bhatt H. Stem cells from primordial germ cells can reenter the germ line. Dev. Biol. 161:1994;626-628.
77. Labosky P.A., Barlow D.P., Hogan B.L. Embryonic germ cell lines and their derivation from mouse primordial germ cells. Ciba Foundation Symposium. 182:1994;157-168. discussion 168-178.
78. Labosky P.A., Barlow D.P., Hogan B.L. Mouse embryonic germ (EG) cell lines: transmission through the germline and differences in the methylation imprint of insulin-like growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines. Development. 120:1994;3197-3204.
79. Durcova-Hills G., Ainscough J., McLaren A. Pluripotential stem cells derived from migrating primordial germ cells. Differentiation. 68:2001;220-226.
80. Horii T., Nagao Y., Tokunaga T., Imai H. Serum-free culture of murine primordial germ cells and embryonic germ cells. Theriogenology. 59:2003;1257-1264.
81. Noguchi T., Stevens L.C. Primordial germ cell proliferation in fetal testes in mouse strains with high and low incidences of congenital testicular teratomas. J. Natl. Cancer Inst. 69:1982;907-913.
82. Pesce M., Scholer H.R. Oct-4: control of totipotency and germline determination. Mol. Reprod. Dev. 55:2000;452-457.
83. Burdon T., Chambers I., Stracey C., Niwa H., Smith A. Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues Organs. 165:1999;131-143.
84. Avilion A.A., Nicolis S.K., Pevny L.H., Perez L., Vivian N., Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17:2003;126-140 An important paper that describes the role of SOX2 in the control of developmental potency in the early embryo.
85. Hanna L.A., Foreman R.K., Tarasenko I.A., Kessler D.S., Labosky P.A. Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev. 16:2002;2650-2661 The authors provide a comprehensive study of the function of FoxD3 and importantly add FoxD3 to the small list of genes that play important roles in the control of pluripotent cells in the embryo.
86. Yeom Y.I., Fuhrmann G., Ovitt C.E., Brehm A., Ohbo K., Gross M., Hubner K., Scholer H.R. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development. 122:1996;881-894.
87. Burdon T., Stracey C., Chambers I., Nichols J., Smith A. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev. Biol. 210:1999;30-43.
88. Burdon T., Smith A., Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12:2002;432-438.
89. Moore F.L., Jaruzelska J., Fox M.S., Urano J., Firpo M.T., Turek P.J., Dorfman D.M., Pera R.A. Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in Azoospermia) and DAZ-like proteins. Proc. Natl. Acad. Sci. USA. 100:2003;538-543.
90. Tanaka S.S., Toyooka Y., Akasu R., Katoh-Fukui Y., Nakahara Y., Suzuki R., Yokoyama M., Noce T. The mouse homolog of Drosophila Vasa is required for the development of male germ cells. Genes Dev. 14:2000;841-853.
91. Lomeli H., Ramos-Mejia V., Gertsenstein M., Lobe C.G., Nagy A. Targeted insertion of Cre recombinase into the TNAP gene: excision in primordial germ cells. Genesis. 26:2000;116-117.
92. Hubner K., Fuhrmann G., Christenson L.K., Kehler J., Reinbold R., De La Fuente R., Wood J., Strauss J.F. III, Boiani M., Scholer H.R. Derivation of oocytes from mouse embryonic stem cells. Science. 300:2003;1251-1256 In addition to be a technical tour de force, this paper describes the use of an Oct4 transgene that is expressed in PGCs but not in ES cells or cells of the ICM.
93. Nakamura Y., Yamamoto M., Matsui Y. Introduction and expression of foreign genes in cultured mouse embryonic gonads by electroporation. Reprod. Fertil. Dev. 14:2002;259-265.
94. Stevens L.C. Development of resistance to teratocarcinogenesis by primordial germ cells in mice. J. Natl. Cancer Inst. 37:1966;859-867.
95. Stallings N.R., Hanley N.A., Majdic G., Zhao L., Bakke M., Parker K.L. Development of a transgenic green fluorescent protein lineage marker for steroidogenic factor 1. Endocr. Res. 28:2002;497-504.
96. Beau C., Vivian N., Munsterberg A., Dresser D.W., Lovell-Badge R., Guerrier D. In vivo analysis of the regulation of the anti-Mullerian hormone, as a marker of Sertoli cell differentiation during testicular development, reveals a multi-step process. Mol. Reprod. Dev. 59:2001;256-264.
97. Szabo P.E., Mann J.R. Biallelic expression of imprinted genes in the mouse germ line: implications for erasure, establishment, and mechanisms of genomic imprinting. Genes Dev. 9:1995;1857-1868.
98. Surani M.A. Reprogramming of genome function through epigenetic inheritance. Nature. 414:2001;122-128.
99. Szabo P.E., Hubner K., Scholer H., Mann J.R. Allele-specific expression of imprinted genes in mouse migratory primordial germ cells. Mech. Dev. 115:2002;157-160.
100. Lee J., Inoue K., Ono R., Ogonuki N., Kohda T., Kaneko-Ishino T., Ogura A., Ishino F. Erasing genomic imprinting memory in mouse clone embryos produced from day 11.5 primordial germ cells. Development. 129:2002;1807-1817.
101. Tada M., Hilton K., Barton S.C., Sado T., Takagi N., Surani M.A. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. Dev. Genes Evol. 207:1998;551-561.
102. Onyango P., Jiang S., Uejima H., Shamblott M.J., Gearhart J.D., Cui H., Feinberg A.P. Monoallelic expression and methylation of imprinted genes in human and mouse embryonic germ cell lineages. Proc. Natl. Acad. Sci. USA. 99:2002;10599-10604.
103. van Gurp R., Oosterhuis W., Kalscheuer V., Mariman E.E.M., Looijenga L. Human testicular germ cell tumors show biallelic expression of the H19 and IGF2 gene. J. Natl. Cancer Inst. 86:1994;1070-1075.
104. Molyneaux K.A., Schaible K., Wylie C. GP130, the shared receptor for the LIF/IL6 cytokine family in the mouse, is not required for early germ cell differentiation, but is required cell-autonomously in oocytes for ovulation. Development. 130:2003;4287-4294.